Hypoglycemia is the major barrier to good glycemic control in patients with diabetes mellitus. Furthermore, randomized controlled trials have emphasized the grave risks associated with severe hypoglycemia in patients with long-standing type 2 diabetes mellitus, and hypoglycemia has also been recognized as a complication of bariatric surgery. New Endocrine Society guidelines on adult hypoglycemic disorders are, therefore, extremely pertinent.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cryer, P. E. et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 94, 709–728 (2009).
De Leon, D. D. & Stanley, C. A. Mechanisms of disease: advance in diagnosis and treatment of hyperinsulinism in neonates. Nat. Clin. Pract. Endocrinol. Metab. 3, 57–68 (2007).
Kompare, M. & Rizzo, W. B. Mitochondrial fatty-acid oxidation disorders. Semin. Pediatr. Neurol. 15, 140–149 (2008).
Service, G. et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N. Engl. J. Med. 353, 249–254 (2005).
Meier, J. J., Butler, A. E., Galasso, R. & Butler, P. C. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 29, 1554–1559 (2006).
Goldfine, A. B. et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J. Clin. Endocrinol. Metab. 92, 4678–4685 (2007).
Dixon, J. B. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299, 316–323 (2008).
Davis, S. N., Fowler, S. & Costa, F. Hypoglycemic counter-regulatory responses differ between men and women with type 1 diabetes. Diabetes 49, 65–72 (2000).
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N. Engl. J. Med. 359, 1464–1476 (2008).
Briscoe, V. J., Ertl, A. C., Tate, D. B. & Davis, S. N. Effects of the selective serotonin reuptake inhibitor fluoxetine on counter-regulatory response to hypoglycemia in individuals with type 1 diabetes. Diabetes 57, 3315–3322 (2008).
Acknowledgements
The author was supported by the following National Institute of Health grants: P50-HL-081009, R01-DK-069803 and P01-HL-056693.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has declared associations with the following companies: Sanofi-Aventis (consultant and grant/research support), Amylin (consultant and grant/research support), and Medtronic MiniMed (grant/research support).
Rights and permissions
About this article
Cite this article
Davis, S. Hypoglycemia—a new approach to an old problem. Nat Rev Endocrinol 5, 243–245 (2009). https://doi.org/10.1038/nrendo.2009.54
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2009.54
